Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rasagiline add-on therapy in ALS patients receiving riluzole
2011-004482-32Phase 2Completed
- Sponsor
- University Hospital Ulm
- Start
- Dec 2012
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in amyotrophic lateral sclerosis (ALS) comparing rasagiline + riluzole with placebo + riluzole (2 arms). Primary endpoint: survival time. Started Dec 2012; status: completed.
02
Drugs
rasagiline
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on 2011-004482-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004482-32.